THYMIDINE KINASE AS A MARKER FOR IMMUNE CHECKPOINT INHIBITOR EFFICACY Application WO-2023209181-A1 World Intellectual Property Organisation (WIPO) 02 Nov 2023
THYMIDINE KINASE AS A MARKER FOR IMMUNE CHECKPOINT INHIBITOR EFFICACY Application WO-2023208361-A1 World Intellectual Property Organisation (WIPO) 02 Nov 2023
COMBINATION OF ENCORAFENIB AND BINIMETINIB AS ADJUVANT TREATMENT FOR RESECTED STAGE II… Application WO-2022074011-A1 World Intellectual Property Organisation (WIPO) 14 Apr 2022